Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy

Nanomedicine: Nanotechnology, Biology and Medicine - Tập 11 - Trang 1133-1140 - 2015
Mark E. Lobatto1,2, Claudia Calcagno1, Maarten J. Otten1, Antoine Millon1,3, Sarayu Ramachandran1, Maarten P.M. Paridaans1, Fleur M. van der Valk2, Gert Storm4,5, Erik S.G. Stroes2, Zahi A. Fayad1, Willem J.M. Mulder1,2, Josbert M. Metselaar4,6
1Translational and Molecular Imaging Institute, Department of Radiology, Icahn School of Medicine at Mount Sinai, NY, NY, United States
2Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
3Department of Vascular Surgery, University Hospital of Lyon, Lyon, France
4Department of Targeted Therapeutics, MIRA Institute, University of Twente, Enschede, The Netherlands
5Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
6Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Nanomedicine: Nanotechnology, Biology and Medicine

Tập 11

1133-1140

Thông tin tác giả